Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0K16 stock hub

LON/0K16 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0K16is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

307.4M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0K16

In the news

Latest news · LON/0K16

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-15.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0K16 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	350
Employees Change	7%
Employees Change Percent	2.17
Enterprise value	$391.9M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US30052C1071
Last refreshed	2026-05-10
Market cap	$307.4M
Price	$14.58
Price currency	USD
Rev Per Employee	652,993.81x
Sector	Healthcare
Sic	2834
Symbol	lon/0K16
Website	https://www.evolus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.7%
EV Earnings	-11.92x
EV/FCF	-12.9x
EV/Sales	1.77x
FCF yield	-9.89%
P/B ratio	-14.1x
P/S ratio	1.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-10.42%
EBITDA Margin	-7.67%
Gross margin	66.06%
Gross Profit	$151M
Gross Profit Growth	5.78%
Gross Profit Growth Q	4.81%
Gross Profit Growth3 Y	25.19%
Gross Profit Growth5 Y	38.37%
Net Income	$-32.9M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-14.1%
Profit Margin	-14.39%
Profit Per Employee	$-93,956
ROA	-9.06
Roa5y	-12.84
ROCE	-20.6
ROIC	-15.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	12.97%
Cagr3y	30%
Cagr5y	4.92%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth	9.56x
Revenue Growth Q	6.74x
Revenue Growth Quarters	24x
Revenue Growth Years	6x
Revenue Growth3 Y	24.49x
Revenue Growth5 Y	38.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.39
Assets	$167.1M
Cash	$37.7M
Current Assets	$101.9M
Current Liabilities	$49.9M
Debt	$124.9M
Debt FCF	$-4.11
Equity	$-21.8M
Interest Coverage	-1.63
Liabilities	$188.9M
Long Term Assets	$65.2M
Long Term Liabilities	$139M
Net Cash	$-87.2M
Net Cash By Market Cap	$-28.36
Tangible Book Value	$-73.3M
Tangible Book Value Per Share	$-1.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.04
Inventory Turnover	5.88
Net Working Capital	$17.9M
Quick ratio	1.5
Working Capital	$53.7M
Working Capital Turnover	$3.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13%
200-day SMA	13.53
3Y total return	119.76%
50-day SMA	12.29
50-day SMA vs 200-day SMA	50under200
5Y total return	27.15%
All Time High	26.02
All Time High Change	-43.96%
All Time High Date	2019-04-23
All Time Low	3.32
All Time Low Change	339.29%
All Time Low Date	2020-12-28
ATR	0.62
Ch YTD	32.23
High	14.58
High52	17.81
High52 Date	2024-10-14
High52ch	-18.11%
Low	14.31
Low52	9.31
Low52 Date	2025-01-14
Low52ch	56.69%
Ma50ch	18.64%
Price vs 200-day SMA	7.73%
RSI	65.9
RSI Monthly	54.44
RSI Weekly	54.74
Sharpe ratio	1x
Sortino ratio	1.99
Total Return	-2.53%
Tr YTD	32.23
Tr1m	34.88%
Tr1w	3.59%
Tr3m	-13.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-23.8M
Operating margin	-10.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,599,037%
Net Borrowing	25,659,053.2
Shares Insiders	11.08%
Shares Institutions	66.84%
Shares Qo Q	-0.25%
Shares Yo Y	2.53%
Short Ratio	5.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-45.4M
Average Volume	3,892.7x
Bv Per Share	-0.33
CAPEX	$-2.7M
Ch1m	34.88
Ch1w	3.59
Ch1y	13
Ch3m	-13.03
Ch3y	119.7
Ch5y	27.16
Ch6m	21.1
Change	0.16%
Change From Open	1.89
Close	14.56
Days Gap	-1.72
Depreciation Amortization	6,080,097.5
Dollar Volume	19,566.4
Earnings Date	2026-05-04
EBIT	$-23.8M
EBITDA	$-17.5M
EPS	$-0.51
F Score	2
FCF	$-30.4M
FCF EV Yield	-7.75x
Financing CF	20,134,468
Fiscal Year End	December
Founded	2,012
Goodwill	15,556,364.9
Income Tax	$652,040
Investing CF	-6,272,000
Is Primary Listing	0
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Ma150	13.6
Ma150ch	7.21%
Ma20	12.2
Ma20ch	19.5%
Net CF	-13,708,735
Next Earnings Date	2026-07-31
Open	14.31
Position In Range	100
Ppne	8,893,857.3
Price Date	2025-01-31
Relative Volume	0.34x
Revenue	228,547,833x
SBC By Revenue	6.59x
Share Based Comp	15,059,767
Tax By Revenue	0.29x
Tr6m	21.1%
Volume	1,342
Z Score	-1.83

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0K16 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0K16 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0K16?

Insider, institutional, and short-interest positioning.

Institutional ownership

+66.8%

Share of float held by funds and institutions

Insider ownership

+11.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0K16 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.9

Neutral momentum band

Price vs 200-day MA

+7.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0K16

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0K16 stock rating?

lon/0K16 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0K16 analysis?

The full report lives at /stocks/lon/0K16/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0K16?

The latest report frames lon/0K16 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0K16 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.